Similar articles

• [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].

  Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC. Danion JM, et al. Encephale. 1984;10(3):135-8. Encephale. 1984. PMID: 6389091 Clinical Trial. French.
• Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.

  Weir JH. Weir JH. J Clin Psychiatry. 1978 Dec;39(12):841-7. J Clin Psychiatry. 1978. PMID: 721788 Clinical Trial.
• A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.

  Goldberg HL, Finnerty RJ. Goldberg HL, et al. Compr Psychiatry. 1977 Mar-Apr;18(2):147-55. doi: 10.1016/0010-440x(77)90058-x. Compr Psychiatry. 1977. PMID: 319941 Clinical Trial. No abstract available.
• Prazepam in anxiety: a controlled clinical trial.

  Rickels K, Sablosky L, Silverman H, Case WG, Rial W, Mirman M, Gottlieb S. Rickels K, et al. Compr Psychiatry. 1977 May-Jun;18(3):239-49. doi: 10.1016/0010-440x(77)90018-9. Compr Psychiatry. 1977. PMID: 858240 No abstract available.
• Prazepam.

  [No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1996;66:143-55. IARC Monogr Eval Carcinog Risks Hum. 1996. PMID: 9097122 Free PMC article. Review. No abstract available.